CHP
ALXN

Cable Hill Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Cable Hill Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-62
Closed -$7K – 940
2018
Q1 		$7K Sell
62
-122
-66% -$14.6K ﹤0.01% 594
2017
Q4 		$23K Sell
184
-276
-60% -$33.6K 0.01% 367
2017
Q3 		$65K Buy
460
+62
+16% +$8.42K 0.03% 209
2017
Q2 		$48K Buy
398
+263
+195% +$30.6K 0.03% 155
2017
Q1 		$16K Hold
135
– – 0.01% 309
2016
Q4 		$17K Sell
135
-5
-4% -$612 0.01% 301
2016
Q3 		$17K Buy
140
+5
+4% +$644 0.01% 318
2016
Q2 		$17K Hold
135
– – 0.01% 281
2016
Q1 		$20K Hold
135
– – 0.02% 241
2015
Q4 		$26K Hold
135
– – 0.02% 205
2015
Q3 		$22K Hold
135
– – 0.02% 238
2015
Q2 		$25K Hold
135
– – 0.02% 251
2015
Q1 		$23K Hold
135
– – 0.02% 259
2014
Q4 		$25K Buy
+135
New +$25K 0.02% 249

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return